Electrovac AG (WBO:EVAC) Research & Development: €1.18 Mil (TTM As of Mar. 2025)


WBO:EVAC Electrovac AG WBO:EVAC
17 GF Score
Price €7.60
View Full Analysis

What is Electrovac AG Research & Development?

Electrovac AG WBO:EVAC +0.80% 17 Research & Development is €1.18 Mil as of Mar. 2025. GuruFocus rates WBO:EVAC with a GF Score™ of 17/100.

Research & Development is the aggregate amount of research and development expenses during the year. Electrovac AG's Research & Development for the six months ended in Mar. 2025 was €1.18 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was €1.18 Mil.

Electrovac AG  (WBO:EVAC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Electrovac AG Research & Development Related Terms

Electrovac AG Research & Development Historical Data

* Premium members only.

The historical data trend for Electrovac AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Electrovac AG Research & Development Chart

Electrovac AG Annual Data
Trend Mar22 Mar23 Mar24 Mar25
Research & Development
1.06 0.96 1.03 1.18

Electrovac AG Semi-Annual Data
Mar22 Mar23 Mar24 Mar25
Research & Development 1.06 0.96 1.03 1.18
WBO:EVAC
17GF Score
Electrovac AG WBO:EVAC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Electrovac AG Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was €1.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €1.18 Mil mean?
Electrovac AG (WBO:EVAC) has a Research & Development of €1.18 Mil as of Mar. 2025. Research and development expense is the total cost for research and development activities. View historical data on Electrovac AG and its competitors.
Is Electrovac AG's Research & Development too high?
Electrovac AG's current Research & Development is €1.18 Mil. Overall, Electrovac AG has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Electrovac AG's Research & Development compare to APH and GLW?
Electrovac AG's Research & Development of €1.18 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Hardware company?
A good Research & Development depends on the Hardware industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Electrovac AG and its competitors. Electrovac AG's current Research & Development is €1.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electrovac AG stock overvalued right now?
Electrovac AG (WBO:EVAC) has a current Research & Development of €1.18 Mil. The current Research & Development is €1.18 Mil. Electrovac AG's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Electrovac AG (WBO:EVAC), the current Research & Development is €1.18 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Electrovac AG Business Description

Other Exchanges EVAC:Germany
Address Anglstrabe 4, Salzweg, BY, DEU, 94121
Electrovac AG is a long-standing world-wide company. It is one of the manufacturers of hermetic packages, glass-to-metal seals, and other specialized components for the reliable and long-term protection of sensitive electronics. In addition to glass-to-metal sealing technology, its core competencies include the production of stamped parts and glass preforms, surface finishing, and the manufacture of contact elements, turned parts, and milled parts.
17GF Score

Get the complete analysis for WBO:EVAC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.60
Price